by Rebecca Birnbaum, MD, and Daniel R. Weinberger, MDOur understanding of the biological mechanisms of schizophrenia risk has steadily evolved over the past few decades, attributable largely to advances in human genetics and to genomic technologies. One of our series of Reports on Progress.
by Jim SchnabelPeople who get migraines could soon have some new therapeutic options, but a deep understanding of the disorder continues to elude researchers.
by Kayt SukelResearchers describe links between the presence of a caregiver, the absence of severe prenatal stress, and changes in brain structure and function in childhood and adolescence.
by Guy McKhann, MD
There are still questions to be answered and procedures to be changed, but there are some exciting new therapeutic approaches to stroke. From our free print publication, Brain in the News.
by Kayt SukelA recent survey suggests that neuromyths are more pervasive
in the educational community than we might think, and this may work against
academic achievement. We investigate some of the most common myths,
explaining their scientific origins and realities. One of our series of briefing papers.
By Jim Schnabel
While most cases of dementia may be unavoidable, a great many may be prevented or delayed via simple changes in diet and other habits. In principle, the earlier in life a person starts making these changes, the better the preventive effect would be.
by Brenda Patoine
Dana grantee Beth Stevens, Ph.D., discusses the unexpected roles immune cells play in normal brain
development and disease. One
of our series of Scientist Q&As.